Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
GlobeNewswire, Inc.
SAN DIEGO, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have...
Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026
GlobeNewswire, Inc.
SAN CARLOS, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need,...
Avaí Bio and Austrianova Present Encapsulated Cell Approach to Sustained α-Klotho Delivery at 2026 Klotho Conference
GlobeNewswire, Inc.
LAS VEGAS, NEVADA, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), together with joint venture partner Austrianova, today announced that Prof. Walter H. Günzburg presented the companies’ encapsulated-cell...
Coave Therapeutics to Present New Data on Wet AMD Gene Therapy Program at 26th Euretina Congress as it Advances towards the Clinic
GlobeNewswire, Inc.
Dr. Nora Dimon, VP of Clinical Development, to present preclinical findings on the Company’s lead retinal program, CoTx-101, including non-human primate data Rodolphe Clerval, CEO, to deliver a corporate presentation at the Euretina Innovation...
JJP Biologics to Present Data Showing the Potential of Nebaprubart for Linear IgA Dermatosis (LAD) at Two Key Upcoming Scientific Conferences
GlobeNewswire, Inc.
Positive interim data from Phase Ib proof-of-concept trial will be presented at the IPPF Scientific Symposium on Pemphigus and Pemphigoid and at EADV Congress 2026 Data positions nebaprubart as a potential therapy across a broad range of...
Governor Meyer Signs Legislation Renaming Delaware Hospital in Honor of Eleanor Cain
Office of the Governor Delaware
FOR IMMEDIATE RELEASE Thursday, September 17, 2026 Media Contact: Jonah Anderson jonah.anderson@delaware.gov SMYRNA, Del. — Joined by state leaders, residents, staff, and members of the Cain family, Governor Matt Meyer today signed legislation...
Cooling Solutions For Medical Equipment Market Forecast Report Featuring Segment Analysis And Strategic Industry Insight
EIN Presswire
The Business Research Company's Cooling Solutions For Medical Equipment Market Forecast Report Featuring Segment Analysis And Strategic Industry Insight LONDON, GREATER LONDON, UNITED KINGDOM, September 16, 2026 /EINPresswire.com/ -- "The demand...
AAVantgarde to Showcase Clinical Progress in Usher 1B and Stargardt Disease at EURetina 2026
GlobeNewswire, Inc.
MILAN, Sept. 16, 2026 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), the clinical-stage biotechnology company developing genetic medicines for inherited retinal diseases (IRDs) using its proprietary dual-AAV technology, today announced...
FROM JANE FONDA TO PRINCESS CHARLÈNE: MAKE‐UP ARTIST KARIM SATTAR JOINS MEDICAL BEAUTY RESEARCH
EIN Presswire
Make-up artist and skincare expert Karim Sattar joins MBR to lead creative artistry, celebrity relations and global brand visibility.
EURETINA: PulseSight Therapeutics to Present Results of Phase 1 clinical trial of PST-611 treatment for dry AMD/Geographic Atrophy (GA)
GlobeNewswire, Inc.
PARIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive non-viral vectorized gene therapies with minimally-invasive delivery technology, will be presenting the...
FemPulse Clinical Data to be Presented at ICS on October 9
GlobeNewswire, Inc.
VIENNA and SAN FRANCISCO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- FemPulse™, a bioelectronic medical technology company with first application overactive bladder (OAB), announced today that data from two recent clinical studies will be presented at the...
Egle Therapeutics to Present Clinical Data at the Upcoming European Academy of Dermatology and Venereology (EADV) Congress in Vienna
GlobeNewswire, Inc.
PARIS, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Egle Therapeutics (“Egle”), a clinical-stage biotechnology company advancing a proprietary therapeutic pipeline targeting T cell (Treg) modulation, announced that it will present new clinical data at the...
Avaí Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for α-Klotho Anti-Aging Therapy
GlobeNewswire, Inc.
LAS VEGAS, NV, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-related disorders, and anti-aging, today...
Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference
GlobeNewswire, Inc.
- Pasithea has been selected to present cutaneous neurofibromas (CN) clinical data in an oral presentation - Pasithea has been selected to present plexiform neurofibromas (PN) clinical data in a poster presentation - The European Neurofibromatosis...
PEPR CLUB CELEBRATES OUTSTANDING ACHIEVEMENTS IN THE 2026 MICHELIN GUIDE HOTEL SELECTION
EIN Presswire
Portfolio of luxury hotel partners shines globally capturing 19 prestigious MICHELIN Keys alongside elite recommended status NEW YORK, NY, UNITED STATES, September 28, 2026 /EINPresswire.com/ -- Following the official release of the 2026...
Slick City and Activeon Accelerate European Expansion with New Parks in Sweden and Austria
GlobeNewswire, Inc.
CHESTERFIELD, Mo., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Slick City Franchise Group, the world’s first indoor slide and air court franchise, today announced plans to open new locations in Gothenburg, Sweden and Vienna, Austria, as the brand continues...
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
GlobeNewswire, Inc.
FREMONT, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- As clinical laboratories seek deeper cellular insights, greater efficiency, and more streamlined approaches to cell analysis, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB)...
F2G Announces Posters Accepted for Presentation at Upcoming Medical Meetings
GlobeNewswire, Inc.
MANCHESTER, United Kingdom, Sept. 01, 2026 (GLOBE NEWSWIRE) -- F2G Ltd., today announced abstracts accepted for presentation at the MSGERC 2026 Biennial Meeting in September and ISPOR Europe 2026 in November.
Sole Searching: Why Foot Health May Be Wellness’s Next Longevity Frontier
EIN Presswire
Hotels and retreats worldwide are putting the feet front and center, as new research ties foot and lower-leg strength to healthy aging.
Rediscovering Her Purpose for Health and Peaceː Dr. Yumi Kisaka Finds Leadership and Growth in Global Career Development Program
UN International Training and Research Center
Despite achieving many of the career goals she had set for herself, Yumi reached a point where she felt it was time to consider the next stage of her professional and personal growth.
Sign up for:
Austria Health Focus
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.